TrialThe New England journal of medicine2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Shanu Modi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,633 papers cite itlatest 60 shown
this paperpooled ittrialcites it